Education
About Us
Working with TipRanks
Follow Us
Schond L Greenway Insider Profile
4 Followers
Schond L Greenway, Chief Financial Officer at Definium Therapeutics, holds 32.18K shares in Definium Therapeutics (Ticker: DFTX). Most recently, Schond L Greenway ― shares of Definium Therapeutics on ― for an estimated value of ―.
Schond L Greenway has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Schond L Greenway's holdings
Insider Roles
Chief Financial Officer
Roles that Schond L Greenway holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Schond L Greenway
Schond L Greenway's Trading History
List of latest transactions for each holding click on a transaction to see Schond L Greenway's performance on stock
You May Also Like
Schond L Greenway insider profile FAQ
What is the percentage of profitable transactions made by Schond L Greenway?
The percentage of profitable transactions made by Schond L Greenway is ―.
What is the average return per transaction made by Schond L Greenway?
The average return per transaction made by Schond L Greenway is ―.
What stocks does Schond L Greenway hold?
Schond L Greenway holds: DFTX stocks.
What was Schond L Greenway’s latest transaction?
Schond L Greenway latest transaction was an Uninformative Buy of ―.
What was Schond L Greenway's most profitable transaction?
Schond L Greenway’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Schond L Greenway's role in Definium Therapeutics?
Schond L Greenway's role in Definium Therapeutics is Chief Financial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.